Translate Bio, Inc. is an early-clinical-stage biotechnology company developing mRNA therapeutics and vaccines targeting protein or gene dysfunction and infectious diseases respectively. Translate Bio ...
Bio Equity Risk Management has formed as a Boston-based investment firm focused on special situations opportunities in the healthcare industry. The firm’s co-founding managing partners are Nessan ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) today announced key management and board appointments in advance of the company’s planned separation, targeted for mid-October, ...
Punishment of both Bio-Rad Laboratories, Inc. and Sartorius AG continued throughout the final stages of 2022. Bio-Rad Laboratories had an equally challenging Q3, setting up Q4 and FY22 numbers as key ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) announced that its management team will participate in two upcoming investor conferences in February and March, where executives will deliver ...
Propel Bio Partners is a leading global venture fund specializing in life science investments, offering a comprehensive ecosystem of experts to empower entrepreneurs to realize their visions. Richard ...
Investors registered to attend the conference who wish to meet with Palisade Bio management should contact the TD Cowen one-on-one desk to request a meeting. Investors registered to attend the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results